4.6 Article

Recommendations from the EGAPP Working Group: can UGT1A1 genotyping reduce morbidity and mortality in patients with metastatic colorectal cancer treated with irinotecan?

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Medical Laboratory Technology

Comparison of three methods for genotyping the UGT1A1 (TA)n repeat polymorphism

Linnea M. Baudhuin et al.

CLINICAL BIOCHEMISTRY (2007)

Article Oncology

UGT1A1 polymorphism can predict hematologic toxicity in patients treated with irinotecan

Jean-Francois Cote et al.

CLINICAL CANCER RESEARCH (2007)

Review Oncology

Adjuvant treatment of colorectal cancer

Brian M. Wolpin et al.

CA-A CANCER JOURNAL FOR CLINICIANS (2007)

Article Pharmacology & Pharmacy

The role of SN-38 exposure, UGT1A1*28 polymorphism, and baseline bilirubin level in predicting severe irinotecan toxicity

Roshni P. Ramchandani et al.

JOURNAL OF CLINICAL PHARMACOLOGY (2007)

Review Oncology

Management of advanced colorectal cancer: state of the art

M. Saunders et al.

BRITISH JOURNAL OF CANCER (2006)

Review Oncology

Optimal treatment of metastatic colorectal cancer

Anna Pessino et al.

EXPERT REVIEW OF ANTICANCER THERAPY (2006)

Article Oncology

Cancer statistics, 2006

A Jemal et al.

CA-A CANCER JOURNAL FOR CLINICIANS (2006)

Letter Medical Laboratory Technology

Rapid detection of UGT1A1 gene polymorphisms by newly developed invader assay

Y Hasegawa et al.

CLINICAL CHEMISTRY (2004)

Article Gastroenterology & Hepatology

The treatment of advanced colorectal cancer: where are we now and where do we go?

E Van Cutsem et al.

BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY (2002)